BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer

Study ID
NCT02458664

Study type
Observational

Study phase

Study status
Unknown status

Trial Acronym

BASE HSP110

Trial Summary

We collect prospectively and retrospectively, patients' demographic, pathological, surgical, therapeutic and prognosis informations in a database. After patient's consent to collect tumoural samples of their colorectal cancer after resection. We will then be able to evaluate the impact of HSP110, a chaperon protein, on their prognosis. Other proteins (to be determined) will also be study, after.

More informations

Trial Starting Date

Nov 30,2013

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

597